StopDownOpen the app

Roundup · Healthcare & Life Sciences

4baseCare raises $9.8 million in Series B

By ·

4baseCare logo
Date
Company
4baseCare
What it does
Healthtech and lifescience B2B company
Kind
Roundup
Amount
$9.8 Mn
Stage
Series B
Founded
2018
Sector
Healthcare & Life Sciences

What they do

4baseCare is a healthtech and lifescience company serving businesses

What happened

It raised $9.8 million in Series B funding led by Ashish Kacholia and Lashit Sanghvi

Why it matters

Yali Capital also participated in the round

The details

  • 4baseCare raised $9.8 million in Series B funding.
  • The round was led by Ashish Kacholia of Lucky Investment Managers and Lashit Sanghvi of Sixth Sense Ventures.
  • Yali Capital also participated in the round.
  • This was part of a week where Indian startups raised $95.6 million across 18 deals.
  • Ashish Kacholia was the most active investor that week with two investments.

About the business

  • 4baseCare is a healthtech and lifescience company.
  • It operates on a B2B model, serving other businesses.
  • The company focuses on healthcare and life sciences technology.

The deal

Type
Series B

Investors

  • Ashish Kacholia (Lucky Investment Managers) (lead)
  • Lashit Sanghvi (Sixth Sense Ventures) (lead)
  • Yali Capital (participated)

About 4baseCare

Product
Genomics-based cancer diagnostic tests and OncoTwin, an AI clinical decision support platform.
Customers
Oncologists, cancer patients, and hospital networks.
How it makes money
Fees for diagnostic testing services and software-driven clinical decision insights.
What sets it apart
Combines clinico-genomic and real-world lifestyle data tailored for underrepresented populations.
Operations
Operates genomics laboratories and partners with hospital networks across emerging markets.

Other articles talking about it

Read it as a card in the app

More on 4baseCare

Everything on 4baseCare →

Same day

All startup news on 31 January 2026 →